Winston Pharmaceuticals, Inc.
WPHM · OTC
12/31/2009 | 12/31/2008 | 9/30/2007 | 9/30/2006 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | -$0 | -$0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 208.2% | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 99.4% | 98.1% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -195.9% | -1,154.7% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -190.4% | -1,136.2% | – | – |
| EPS Diluted | -0.04 | -0.1 | -0.08 | -0.8 |
| % Growth | 60% | -25% | 90% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |